Beth Israel Deaconess Medical Center
Louis J. Kang is an experienced professional currently serving as a Member of the Leadership Board at Beth Israel Deaconess Medical Center since October 2022. As a Partner at ACCELR8, a VC fund focused on climate change mitigation, and Co-Founder of March Therapeutics, Inc., which develops novel genetic medicines, Louis has demonstrated a commitment to impactful ventures. Additionally, Louis acts as an Advisor for Woori Venture Partners US, the VC arm of a major South Korean bank. With a diverse background in various projects addressing global challenges and previous experience as an Associate & Ambassador at The Thiel Foundation, Louis combines extensive expertise in applied physics, electrical engineering, and materials science, obtained through a Ph.D. from Harvard University and a B.S. from the University of California, Berkeley.
This person is not in the org chart
This person is not in any teams
Beth Israel Deaconess Medical Center
1 followers
Beth Israel Deaconess Medical Center (BIDMC) is part of Beth Israel Lahey Health, a new health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education. BIDMC is a world-class teaching hospital of Harvard Medical School and is located in the heart of Boston. We are passionate about caring for our patients like they are family, finding new cures, using the finest and the latest technologies, and teaching and inspiring caregivers of tomorrow. We put people at the center of everything we do, because we believe in medicine that puts people first. Interested in a career at BIDMC? Check out www.jobs.bidmc.org.